Find clinical trials for Multiple Myeloma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Indianapolis, IN, USA:
This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...
Phase 1
Indianapolis, Indiana, United States and 13 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Indianapolis, Indiana, United States and 31 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Indianapolis, Indiana, United States and 59 other locations
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...
Phase 4
Indianapolis, Indiana, United States and 12 other locations
provide clinical benefit in participants with relapsed/refractory multiple myeloma. Elranatamab is a bispecific antibody: binding o ...
Phase 2
Indianapolis, Indiana, United States and 77 other locations
B-cell maturation antigen (BCMA) is a target present on tumor cells in participants with multiple myeloma. Belantamab mafodotin (GS...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 58 other locations
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percentage (%) of all cancers and for 10% of all hematologic ma ...
Phase 2
Indianapolis, Indiana, United States and 58 other locations
The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to ide...
Phase 1
Indianapolis, Indiana, United States and 26 other locations
The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to id...
Phase 1
Indianapolis, Indiana, United States and 30 other locations
participants with relapsed/refractory multiple myeloma. Dexamethasone standard dose will be administered with one or more selected...
Phase 1, Phase 2
Noblesville, Indiana, United States and 94 other locations
Clinical trials
Research sites
Resources
Legal